Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase - PubMed (original) (raw)
Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase
Elise E DeVito et al. Neuropsychopharmacology. 2014 May.
Abstract
Nicotine dependence is a serious public health concern. Optimal treatment of nicotine dependence will require greater understanding of the mechanisms that contribute to the maintenance of smoking behaviors. A growing literature indicates sex and menstrual phase differences in responses to nicotine. The aim of this study was to assess sex and menstrual phase influences on a broad range of measures of nicotine response including subjective drug effects, cognition, physiological responses, and symptoms of withdrawal, craving, and affect. Using a well-established intravenous nicotine paradigm and biochemical confirmation of overnight abstinence and menstrual cycle phase, analyses were performed to compare sex (age 18-50 years; 115 male and 45 female) and menstrual cycle phase (29 follicular and 16 luteal) effects. Females had diminished subjective drug effects of, but greater physiological responses to, nicotine administration. Luteal-phase females showed diminished subjective drug effects and better cognition relative to follicular-phase women. These findings offer candidate mechanisms through which the luteal phase, wherein progesterone is dominant relative to estradiol, may be protective against vulnerability to smoking.
Figures
Figure 1
Influence of sex and phase on subjective and physiological IV dose effects. *Significant (_p⩽_0.05) effect of sex or phase; †significant (_p⩽_0.05) sex-by-dose or phase-by-dose interaction.
Figure 2
Influence of menstrual cycle phase on affect, cognitive performance, and craving. *Significant (_p⩽_0.05) effect of phase; ∼trend (0.5<p<0.1) effect of phase-by-timepoint; ↓indicates that lower scores represent more optimal cognitive task performance.
References
- al'Absi M, Amunrud T, Wittmers LE. Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers. Pharmacol Biochem Behav. 2002;72:707–716. - PubMed
- Allen SS, Bade T, Hatsukami D, Center B. Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse. Nicotine Tob Res. 2008;10:35–45. - PubMed
- Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci. 2011;8:73–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA012690/DA/NIDA NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- K12 DA000167/DA/NIDA NIH HHS/United States
- R03 DA027474/DA/NIDA NIH HHS/United States
- R01 DA12849/DA/NIDA NIH HHS/United States
- K12 DA00167/DA/NIDA NIH HHS/United States
- K12 DA031050/DA/NIDA NIH HHS/United States
- R01 DA12690/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical